Sat, Jun 7, 2025
[Archive]
Volume 27, Issue 122 (May & June 2019)
J Adv Med Biomed Res 2019, 27(122): 35-41 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Jafari A, Arazi H, Ghadian A, Hesrak K. The Impact of Combined (Aerobic-resistance) Training on Serum Levels of IGF-I and IGFBP-3 in Men with Prostate Cancer. J Adv Med Biomed Res 2019; 27 (122) :35-41
URL: http://journal.zums.ac.ir/article-1-5299-en.html
URL: http://journal.zums.ac.ir/article-1-5299-en.html
1- Dept. of Exercise Physiology, Faculty of Sport Sciences, University of Guilan, Rasht, Iran
2- Dept. of Exercise Physiology, Faculty of Sport Sciences, University of Guilan, Rasht, Iran ,2- Hamidarazi@yahoo.com
3- Dept. of Kidney and Urethral Cancers, Baqiyatallah Al-Azam Hospital, Tehran, Iran
4- Dept. of Molecular Medicine, Baqiyatallah Al-Azam Hospital, Tehran, Iran
2- Dept. of Exercise Physiology, Faculty of Sport Sciences, University of Guilan, Rasht, Iran ,
3- Dept. of Kidney and Urethral Cancers, Baqiyatallah Al-Azam Hospital, Tehran, Iran
4- Dept. of Molecular Medicine, Baqiyatallah Al-Azam Hospital, Tehran, Iran
Abstract: (146228 Views)
Background & Objective: Prostate cancer is the most common cancer in men. The purpose of this study was to determine the effect of combined training (aerobic-resistance) on serum levels of insulin-like growth factor-I (IGF-I) and insulin-like growth factor-binding proteins 3 (IGFBP-3) in men with prostate cancer.
Materials & Methods: 20 eligible men with prostate cancer with an average age of 62.6±7.71 years, height of 172.15±5.02 cm, average weight of 75.6±11.6 kg, and the body mass index 25.54±3.47 were divided randomly into two groups (10 individuals each): the control and experimental groups. The experimental group experienced eight weeks of combined training (Aerobic resistance) with three sessions per week. During this period the control group did not participate in any exercise. At the beginning and the end of the period, 5 mL blood samples were taken to measure serum levels of IGF-I and IGFBP-3. The obtained data were then analyzed using ANCOVA with P-value≤ 0.05.
Results: The results showed that the eight weeks of combined training significantly reduced the level of IGF-I in the experimental group (P=0.001). Also, the combined training significantly increased the level of IGFBP-3 in the experimental group, which was significantly different from the control group (P=0.036).
Conclusion: The results of this study indicate that the combined training can affect some of the factors associated with prostate cancer and may be able to contribute to the improvement of patients' disease (along with the main treatment protocol).
Full-Text [PDF 635 kb]
(156736 Downloads)
| | Full-Text (HTML) (3084 Views)
✅ The results of this study indicate that the combined training can affect some of the factors associated with prostate cancer and may be able to contribute to the improvement of patients' disease (along with the main treatment protocol).
Type of Study: Original Research Article |
Subject:
Clinical Medicine
Received: 2018/08/9 | Accepted: 2019/02/20 | Published: 2019/05/10
Received: 2018/08/9 | Accepted: 2019/02/20 | Published: 2019/05/10
References
1. Lujan M, Paez A, Llanes L, Miravalles E, Berenguer A. Prostate-specific antigen density. Is there a role for this parameter when screening for prostate cancer? Prostate cancer and prostatic diseases. 2001; 4(3): 146. [DOI:10.1038/sj.pcan.4500509] [PMID]
2. Siegel R, Naishadham D, Jemal A. Cancer statistics for hispanics/latinos, 2012. CA: a Cancer J Clin. 2012; 62(5): 283-98. [DOI:10.3322/caac.21153] [PMID]
3. Siegel R, Ma J, Zou Z, Jemal A. Cancer statistics, 2014. CA: A Cancer J Clin. 2014; 64(1): 9-29. [DOI:10.3322/caac.21208] [PMID]
4. Hosseini M, SeyedAlinaghi S, Mahmoudi M, McFarland W. A case-control study of risk factors for prostate cancer in Iran. Acta Med Iran. 2010; 48(1): 61.
5. Noori Daloia MR eVEMg, diagnosis, prevention and gene therapy in prostatic cancer: review article. Tehran Univ Med J. 2009; 67(1): 1-14.
6. Janssen J, Jacobs M, Derkx F, Weber R, van der Lely A-J, Lamberts S. Free and total insulin-like growth factor I (IGF-I), IGF-binding protein-1 (IGFBP-1), and IGFBP-3 and their relationships to the presence of diabetic retinopathy and glomerular hyperfiltration in insulin-dependent diabetes mellitus. J Clin End Meta. 1997; 82(9): 2809-15.
https://doi.org/10.1210/jcem.82.9.4180 [DOI:10.1210/jc.82.9.2809] [PMID]
7. Devin JL, Bolam KA, Jenkins DG, Skinner TL. The influence of exercise on the insulin-like growth factor axis in oncology: physiological basis, current and future perspectives. Cancer Epid Biom Prev. 2016; 25(2): 239-249. [DOI:10.1158/1055-9965.EPI-15-0406] [PMID]
8. Santa Mina D, Connor KM, Alibhai Sh, et al. Exercise effects on adipokines and the IGF axis in men with prostate cancer treated with androgen deprivation: A randomized study. Can Urol Assoc J. 2013; 7(11-12): E692-E698. [DOI:10.5489/cuaj.235] [PMID] [PMCID]
9. Maki RG. Small is beautiful: insulin-like growth factors and their role in growth, development, and cancer. J Clin Oncol. 2010; 28(33): 4985-95. [DOI:10.1200/JCO.2009.27.5040] [PMID] [PMCID]
10. Cohen P, Peehl DM, Lamson G, Rosenfeld RG. Insulin-like growth factors (IGFs), IGF receptors, and IGF-binding proteins in primary cultures of prostate epithelial cells. J Clin End Metab. 1991; 73(2): 401-7. [DOI:10.1210/jcem-73-2-401] [PMID]
11. Hursting SD, Lavigne JA, Berrigan D, Perkins SN, Barrett JC. Calorie restriction, aging, and cancer prevention: mechanisms of action and applicability to humans. Ann Rev Med. 2003; 54(1): 131-52. [DOI:10.1146/annurev.med.54.101601.152156] [PMID]
12. Baglietto L, English DR, Hopper JL, Morris HA, Tilley WD, Giles GG. Circulating insulin-like growth factor-I and binding protein-3 and the risk of breast cancer. Cancer Epid Prev Biom. 2007; 16(4): 763-8. [DOI:10.1158/1055-9965.EPI-06-0960] [PMID]
13. Collett-Solberg PF, Cohen P. The role of the insulin-like growth factor binding proteins and the IGFBP proteases in modulating IGF action. End Metab Clin. 1996; 25(3): 591-614. [DOI:10.1016/S0889-8529(05)70342-X]
14. Kurek R, Tunn UW, Eckart O, et al. The significance of serum levels of insulin-like growth factor-1 in patients with prostate cancer. Br J Urol Int. 2002; 85(1): 125-29. [DOI:10.1046/j.1464-410x.2000.00350.x] [PMID]
15. Renehan AG, Zwahlen M, Minder C, T O'Dwyer S, Shalet SM, Egger M. Insulin-like growth factor (IGF)-I, IGF binding protein-3, and cancer risk: systematic review and meta-regression analysis. Lancet. 2004; 363(9418): 1346-53. [DOI:10.1016/S0140-6736(04)16044-3]
16. Wall B, Galvao D, Fatehee N, et al. Exercise improves Vo2max and body composition in ADT-treated prostate cancer patients: 1240 Board# 4 June 1 8. Med Scie Sports Exerc. 2017; 49: 333-4. [DOI:10.1249/01.mss.0000517784.17673.03]
17. Coburn JW, Malek MH. NSCA's Essentials of Personal Training 2nd Edition: Human Kinetics; 2012.
18. Schmitz KH, Courneya KS, Matthews C, et al. American College of Sports Medicine roundtable on exercise guidelines for cancer survivors. Med Scie Sports Exerc. 2010; 42(7): 1409-26. [DOI:10.1249/MSS.0b013e3181e0c112] [PMID]
19. Tofighi A, Dehkordi AJ, Tartibian B, Shourabeh FF, Sinaei M. Effects of aerobic, resistance, and concurrent training on secretion of growth hormone and insulin-like growth factor-1 in elderly women. J Isfahan Med School. 2012; 30(184).
20. Seo DI, Jun TW, Park KS, Chang H, So WY, Song W. 12 weeks of combined exercise is better than aerobic exercise for increasing growth hormone in middle-aged women. Int J Sport Nutr Exerc Metab. 2010; 20(1): 21-6. [DOI:10.1123/ijsnem.20.1.21] [PMID]
21. Rosendal L, Langberg H, Flyvbjerg A, Frystyk J, Ørskov H, Kjær M. Physical capacity influences the response of insulin-like growth factor and its binding proteins to training. J Appl Phy. 2002; 93(5): 1669-75. [DOI:10.1152/japplphysiol.00145.2002] [PMID]
22. Irwin ML, Varma K, Alvarez-Reeves M, et al. Randomized controlled trial of aerobic exercise on insulin and insulin-like growth factors in breast cancer survivors: the Yale Exercise and Survivorship study. Cancer Epid Prev Biom. 2009; 18(1): 306-13. [DOI:10.1158/1055-9965.EPI-08-0531] [PMID] [PMCID]
23. Schmitz KH, Ahmed RL, Hannan PJ, Yee D. Safety and efficacy of weight training in recent breast cancer survivors to alter body composition, insulin, and insulin-like growth factor axis proteins. Cancer Epid Prev Biom. 2005; 14(7): 1672-80. [DOI:10.1158/1055-9965.EPI-04-0736] [PMID]
24. Stattin Pr, Bylund A, Rinaldi S, et al. Plasma insulin-like growth factor-I, insulin-like growth factor-binding proteins, and prostate cancer risk: a prospective study. J Nati Cancer Ins. 2000; 92(23): 1910-7. [DOI:10.1093/jnci/92.23.1910] [PMID]
25. Giovannucci EL, Liu Y, Leitzmann MF, Stampfer MJ, Willett WC. A prospective study of physical activity and incident and fatal prostate cancer. Arch Int Med. 2005; 165(9): 1005-10. [DOI:10.1001/archinte.165.9.1005] [PMID]
26. Tung Ngo H, James Barnard R, Christopher N Tymchuk, Pinchas Cohen, William J Aronson. Effect of diet and exercise on serum insulin, IGF-I, and IGFBP-1 levels and growth of LNCaP cells in vitro (United States). Cancer Causes Control. 2002; 13: 929-935. [DOI:10.1023/A:1021911517010] [PMID]
27. Singh MAF, Ding W, Manfredi TJ, et al. Insulin-like growth factor I in skeletal muscle after weight-lifting exercise in frail elders. Am J Phy Endocrinol Metab 1999; 277(1): E135-E43. [DOI:10.1152/ajpendo.1999.277.1.E135] [PMID]
28. Bang P, Brandt J, Degerblad M, et al. Exercise-induced changes in insulin-like growth factors and their low molecular weight binding protein in healthy subjects and patients with growth hormone deficiency. Eur J Clin Investi. 1990; 20(3): 285-92. [DOI:10.1111/j.1365-2362.1990.tb01857.x] [PMID]
29. Nindl BC, Kraemer WJ, Marx JO, et al. Overnight responses of the circulating IGF-I system after acute, heavy-resistance exercise. J Appl Physiol. 2001; 90(4): 1319-26. [DOI:10.1152/jappl.2001.90.4.1319] [PMID]
30. Di Luigi L, Guidetti L. IGF-I, IGFBP2, and-3: do they have a role in detecting rh GH abouse in trained men? Med Sci Sports exercise. 2002; 195: 1270-1278. [DOI:10.1097/00005768-200208000-00007] [PMID]
31. Orciari S, Di Nuzzo S, Lazzarini R, Caprari P, Procopio A, Catalano A. The effects of insulin and insulin-like growth factors on tumor vascularization: new insights of insulin-like growth factor family in cancer. Curr Medicinal Chem. 2009; 16(30): 3931-42. [DOI:10.2174/092986709789352268] [PMID]
32. Kurek R, Tunn U, Eckart O, Aumüller G, Wong J, Renneberg H. The significance of serum levels of insulin-like growth factor-1 in patients with prostate cancer. BJU Int. 2000; 85(1): 125-9. [DOI:10.1046/j.1464-410x.2000.00350.x] [PMID]
33. Khosravi J, Diamandi A, Mistry J, Scorilas A. Insulin-like growth factor I (IGF-I) and IGF-binding protein-3 in benign prostatic hyperplasia and prostate cancer. J Clin End Metab. 2001; 86(2): 694-9. [DOI:10.1210/jcem.86.2.7211] [PMID]
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
Copyright Policy
